ePrints

Recommended guidelines for screening for underlying malignancy in extramammary Paget's disease based on anatomic subtype

Lookup NU author(s): Professor Neil RajanORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2024 American Academy of Dermatology, Inc. Introduction: Extramammary Paget's disease (EMPD) may be associated with an underlying internal adenocarcinoma, referred to as secondary EMPD. Differences in this association by EMPD anatomic subtype and implications for screening are not fully understood. Objective: Define the rates of secondary EMPD and types of associated adenocarcinomas by EMPD anatomic subtype and propose a screening algorithm for underlying adenocarcinoma. Methods: Systematic literature review of EMPD (January 1990-November 2022). One hundred twenty-two studies met the inclusion criteria. A multidisciplinary expert panel reviewed the recommendation statements on adenocarcinoma screening. Results: Perianal EMPD was associated with a high rate of underlying adenocarcinoma (25%, primarily colorectal) compared with penoscrotal and vulvar EMPD (6% each, primarily of genitourinary origin). Thorough screening in perianal EMPD includes a colonoscopy, urine cytology, and computed tomography of the chest, abdomen, and pelvis. Cost-conscious screening tests in low-risk penoscrotal disease include urine cytology, heme-occult test, and prostate-specific antigen test (especially if under 70 years of age). For low-risk vulvar EMPD, urine cytology and mammography are recommended. EMPD with high-risk features may warrant more sensitive organ-specific testing. Limitations: Selection bias; retrospective data without systematic follow-up. Conclusions: Screening for underlying adenocarcinoma in EMPD should be guided by anatomic location.

Publication metadata

Author(s): Kibbi N, Owen JL, Worley B, Alam M, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Brian Jiang SI, John EM, Kanitakis J, Keimig EL, Khan A, Linos E, Kim JYS, Kuzel TM, Lawrence N, Leitao MM, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Rajan N, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Brackett A, Poon E, Ahmed A

Publication type: Article

Publication status: Published

Journal: Journal of the American Academy of Dermatology

Year: 2024

Pages: Epub ahead of print

Online publication date: 12/10/2024

Acceptance date: 13/07/2024

ISSN (print): 0190-9622

ISSN (electronic): 1097-6787

Publisher: Elsevier Inc.

URL: https://doi.org/10.1016/j.jaad.2024.07.1531

DOI: 10.1016/j.jaad.2024.07.1531

PubMed id: 39401611

Altmetrics

Share